Skip to main content
. 2017 Feb 9;13(4):1347–1352. doi: 10.3892/etm.2017.4112

Figure 2.

Figure 2.

The expressions of NF-κB under immunohistochemical staining (x400, from the left to right: 1, 7, 14 and 21 days in turn, and from top to bottom: The model group, HBD-3 group and vancomycin group in turn). NF-κB, nuclear factor-κB; HBD-3, human β-defensin 3.